Selecta Biosciences, Inc.
Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses

Last updated:

Abstract:

Disclosed are synthetic nanocarrier compositions that provide controlled release of immunosuppressants as well as related methods. The synthetic nanocarrier compositions may also include antigen in some embodiments.

Status:
Grant
Type:

Utility

Filling date:

6 Aug 2018

Issue date:

1 Feb 2022